슬로베니아 - 슬로베니아어 - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

krka, d.d., novo mesto - amjodaron - tableta - amjodaron 189,3 mg / 1 tableta - amjodaron

슬로베니아 - 슬로베니아어 - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

sanofi-aventis d.o.o. - amjodaron - tableta - amjodaron 189,3 mg / 1 tableta - amjodaron

슬로베니아 - 슬로베니아어 - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

krka, d.d., novo mesto - amjodaron - raztopina za injiciranje/infundiranje - amjodaron 47,33 mg / 1 ml - amjodaron

슬로베니아 - 슬로베니아어 - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

sanofi-aventis d.o.o. - amiodaron - raztopina za injiciranje/infundiranje - amiodaron 47,3 mg / 1 ml - amjodaron

슬로베니아 - 슬로베니아어 - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

sanofi-aventis d.o.o. - amiodaron - tableta - amiodaron 189,3 mg / 1 tableta - amjodaron

유럽 연합 - 슬로베니아어 - EMA (European Medicines Agency)

janssen-cilag international nv - kanaglifozin - diabetes mellitus, tip 2 - zdravila, ki se uporabljajo pri diabetesu - invokana is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise:as monotherapy when metformin is considered inappropriate due to intolerance or contraindicationsin addition to other medicinal products for the treatment of diabetes. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 in 5.

유럽 연합 - 슬로베니아어 - EMA (European Medicines Agency)

merck sharp & dohme b.v. - elbasvir, grazoprevir - hepatitis c, kronični - direct acting antivirals, antivirals for systemic use, antivirals for treatment of hcv infections - zepatier is indicated for the treatment of chronic hepatitis c (chc) in adult and paediatric patients 12 years of age and older who weigh at least 30 kg (see sections 4. 2, 4. 4 in 5. za virus hepatitisa c (hcv) genotip-specifična aktivnost glej točki 4. 4 in 5.

유럽 연합 - 슬로베니아어 - EMA (European Medicines Agency)

astellas pharma europe b.v. - gilteritinib fumarate - leukemija, myeloid, akutna - antineoplastična sredstva - xospata je označen kot monotherapy za zdravljenje odraslih bolnikov, ki so relapsed ali ognjevzdržni akutno mieloično levkemijo (aml), z flt3 mutacija.

슬로베니아 - 슬로베니아어 - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

amjodaron - raztopina za infundiranje - amjodaron 18,93 mg / 1 ml - amjodaron

유럽 연합 - 슬로베니아어 - EMA (European Medicines Agency)

novartis europharm limited  - capmatinib dihydrochloride monohydrate - karcinom, pljučni pljuč - antineoplastična sredstva - tabrecta as monotherapy is indicated for the treatment of adult patients with advanced non small cell lung cancer (nsclc) harbouring alterations leading to mesenchymal epithelial transition factor gene exon 14 (metex14) skipping, who require systemic therapy following prior treatment with immunotherapy and/or platinum based chemotherapy.